BZNE Stock Alert Biozone Pharmaceuticals, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Biozone Pharmaceuticals, Inc. BZNE Company Overview 

Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt1=Go!

Biozone Pharmaceuticals, Inc. BZNE Current Price and Quotes
Last Price 0.565
Previous Close 0.59 Open 0.61
Daily Range 0.61 - 0.55 52wk Range 3.75 - 0.16
Volume 5,468,959 Dividend N/A
Average Vol (3m) 212,228 Yield N/A
Biozone Pharmaceuticals, Inc. BZNE
Company Information

550 Sylvan Avenue
Suite 101
Englewood Cliffs, NJ 07632

Phone: 201-608-5101

Biozone Pharmaceuticals, Inc. BZNE
Biozone Pharmaceuticals, Inc. BZNE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001412486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Dec 31, 0007
Incorporated In: NV, USA
Year of Inc. 2006
Employees Not Available
Company Officers/Contacts

Elliot Maza Interim CEO, CFO
Roberto Prego Novo President, Principal Acct. Officer
Company Directors

Roberto Prego Novo
Company Notes

Formerly=International Surf Resorts, Inc. until 3-2011
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
M2 Law Professional Corp.
500 Newport Center Dr.
Newport Beach, CA, 92660
United States

Investor Relations Firm
Not Available

Biozone Pharmaceuticals, Inc. BZNE
BZNE Security Details

Share Structure

Market Value1 $41,070,682 a/o Sep 30, 2013
Shares Outstanding 69,611,325 a/o Jul 31, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 257 a/o Apr 01, 2013
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.00) Mar 15, 2011 Mar 11, 2011 Mar 14, 2011
Security Notes

Capital Change=shs increased by 10 for 1 split. Ex-date=03/15/2011. Rec date=03/11/2011. Pay date=03/14/2011.
Short Selling Data

Short Interest 1,900 (68.74%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Biozone Pharmaceuticals, Inc. BZNE Recent News

Biozone Pharmaceuticals, Inc. BZNE Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 17,191 12,605 15,254 -
Cost of Revenue 9,969 9,920 8,428 -
Gross Profit 7,222 2,686 6,826 -
Operating Expenses

Research and Development 743 423 241 -
Sales, General and Admin. 9,115 6,149 6,617 9
Non-Recurring Items - - - 34
Other - - - -
Operating Income (2,637) (3,887) (32) (43)
Income From Continuing Operations

Add'l Income/Expense Items 154 (282) - -
Earnings Before Interest and Tax (2,483) (4,211) 23 (43)
Interest Expense 5,482 1,243 439 -
Earnings Before Tax (7,965) (5,454) (416) (43)
Income Tax - 3 (96) -
Minority Interest - - - (1)
Equity Earnings Unconsolidated Subsidiary - (43) 55 -
Net Income Cont. Operations (7,965) (5,500) (265) (41)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,965) (5,457) (320) (41)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,965) (5,457) (320) (41)

BZNE Biozone Pharmaceuticals, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BZNE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BZNE/quote
Stock Chart http://www.otcmarkets.com/stock/BZNE/chart
Company Info http://www.otcmarkets.com/stock/BZNE/company-info
Recent News http://www.otcmarkets.com/stock/BZNE/news
Financials http://www.otcmarkets.com/stock/BZNE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BZNE/filings
Short Sales http://www.otcmarkets.com/stock/BZNE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BZNE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BZNE/research
Summary http://finance.yahoo.com/q?s=BZNE
Historical Prices http://finance.yahoo.com/q/hp?s=BZNE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BZNE
Basic Chart http://finance.yahoo.com/q/bc?s=BZNE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BZNE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BZNE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BZNE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BZNE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BZNE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BZNE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BZNE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BZNE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BZNE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BZNE
Balance Sheet http://finance.yahoo.com/q/bs?s=BZNE
Cash Flow http://finance.yahoo.com/q/cf?s=BZNE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BZNE
Market Watch http://www.marketwatch.com/investing/stock/BZNE
Bloomberg http://www.bloomberg.com/quote/BZNE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BZNE
Bussinessweek http://investing.businessweek.com/research/st...icker=BZNE
Barchart http://www.barchart.com/quotes/stocks/BZNE
OTC Short Report http://otcshortreport.com/index.php?index=BZNE
Investopedia http://www.investopedia.com/markets/stocks/BZNE/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arkestro Recognized as Leading Sourcing Tech Solution in 2024

Updated Category News Views 138

Arkestro Celebrated as a Leading Sourcing Technology Provider Arkestro's innovative Predictive Procurement Orchestration AI platform has been recognized among the top contenders in the industry. This recognition comes as part of Spend Matters' release of their Fall 2024 SolutionMap, which acknowledges the leading procurement technology vendors. Out of 93 companies...

Continue Reading
Nanoscope Therapeutics Welcomes Ademola Daramola as VP of Quality

Updated Category News Views 178

Nanoscope Therapeutics Expands Leadership Team Nanoscope Therapeutics Inc., a dedicated biotechnology firm, strives to restore vision for blind patients through pioneering gene therapies. The company has recently appointed Ademola Daramola, D.Sc., as the Vice President of Quality and Compliance. Introducing Dr. Ademola Daramola Dr. Daramola joins Nanoscope with an...

Continue Reading
Lumentum Holdings Readies for Earnings Report with Optimism

Updated Category News Views 220

Lumentum Holdings Prepares for Earnings Release Lumentum Holdings (NASDAQ: LITE) is set to announce its quarterly earnings soon. Investors are eager to see what insights will emerge from the report, as expectations build around the company's performance. Investor Expectations and Earnings Forecast Analysts predict that Lumentum Holdings will post an earnings per share...

Continue Reading
LightPath Technologies Launches Infrared Solutions for Defense

Updated Category News Views 130

LightPath Technologies Initiates Delivery of Infrared Assemblies FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025 LightPath Technologies, Inc. (NASDAQ: LPTH), renowned for its advanced optics and imaging systems targeted at both defense and commercial utilizations, has announced that it...

Continue Reading
The RealReal Boosts Revenue and Adjusted EBITDA in Q3 2024

Updated Category News Views 57

Strong Q3 2024 Performance for The RealReal The RealReal (NASDAQ: REAL), a leader in the online marketplace for authenticated, resale luxury goods, reported significant financial gains in the third quarter of 2024. The company achieved a revenue of $148 million, which represents an increase of $15 million or 11% compared to the previous year. Notably, they also saw...

Continue Reading